Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northern Ophthalmic Associates is a leading ophthalmology group in the Philadelphia region, offering advanced surgical and medical treatment for cataract, glaucoma, macular degeneration, and other ocular diseases. They are involved in private clinical research on new cataract lens technology but do not develop proprietary drugs or biologics in-house as a traditional biotech or pharma company. Their physicians are involved in clinical teaching and research, contributing to technological advancement within ophthalmology, particularly cataract and refractive surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northern Ophthalmic Associates.